Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-09-17

FDA Approved: ZALEPLON — Original Application (Bionpharma Inc.)

View source ↗

Summary

FDA approved the original application for Zaleplon from Bionpharma Inc., enabling the generic version of Zaleplon to be marketed for insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zaleplon (Zaleplon)

Snippet

ORIG AP for ZALEPLON (ZALEPLON)